Skip to main content
TYRA
NASDAQ Life Sciences

RA Capital Discloses $200M Pre-Funded Warrant Purchase in Tyra's $400M Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$24.43
Mkt Cap
$1.458B
52W Low
$12.115
52W High
$40.65
52W Position info
102% above low
Off High info
40% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

TYRA has more than doubled off its 52-week low of $12.115.

Summary

RA Capital Management disclosed a $200M purchase of pre-funded warrants in Tyra Biosciences' recent $400M offering, bringing its beneficial ownership to 19.99% of the company.


Key Events · Ownership and Investor Activity · TYRA

  • RA Capital Purchases $200M in Pre-Funded Warrants

    RA Capital Healthcare Fund acquired 9,078,529 pre-funded warrants at $22.029 per warrant for an aggregate purchase price of $199,990,915.34 in the September 2026 Offering.

  • Beneficial Ownership Reaches 19.99% Cap

    RA Capital's beneficial ownership is 19.99% of Tyra's common stock, the maximum allowed under the Pre-Funded Warrants' Beneficial Ownership Blocker, which currently limits exercise to 14,130,492 shares.

  • Warrant Terms: $0.001 Exercise Price, No Expiration

    The pre-funded warrants have an exercise price of $0.001 per share, are immediately exercisable, and do not expire, with standard anti-dilution adjustments for stock splits and dividends.

  • Follows $400M Underwritten Offering

    This purchase is part of Tyra's $400M underwritten offering of 9.08M common shares and 9.08M pre-funded warrants priced at $22.03 per share, announced September 14, 2026.


Analysis · TYRA · Life Sciences

RA Capital Management, a major healthcare investor, purchased $199,990,915.34 of pre-funded warrants in Tyra Biosciences' September 2026 offering, acquiring warrants exercisable for 9,078,529 shares at $22.029 per warrant. This brings RA Capital's beneficial ownership to 19.99% of Tyra's common stock, the maximum allowed under the warrant's Beneficial Ownership Blocker. The purchase represents a significant vote of confidence from a sophisticated life sciences investor, but also creates a substantial overhang of potentially exercisable shares. The 19.99% cap means RA Capital cannot exercise additional warrants without triggering the blocker, limiting immediate dilution but signaling strong institutional demand for Tyra's equity.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TYRA was trading at $24.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $12.12 to $40.65. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TYRA - Latest Insights

TYRA
Nov 10, 2026, 8:05 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.25
Real-time Price: $20.03 info
Change: -$2.23 (-10%) info
Market Cap: $1.383B info
TYRA
Nov 10, 2026, 8:03 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.25
Real-time Price: $20.03 info
Change: -$2.23 (-10%) info
Market Cap: $1.383B info
TYRA
Sep 14, 2026, 7:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.20
Real-time Price: $20.03 info
Change: -$5.18 (-21%) info
Market Cap: $1.383B info
TYRA
Sep 14, 2026, 7:09 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $25.20
Real-time Price: $20.03 info
Change: -$5.18 (-21%) info
Market Cap: $1.383B info
TYRA
Sep 14, 2026, 6:45 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $21.70
Real-time Price: $20.03 info
Change: -$1.68 (-8%) info
Market Cap: $1.383B info